Bethesda, Md., February 27, 2017 – The Parenteral Drug Association (PDA) today announced the completion of a six-month enlargement of its Training and Research Institute (TRI) in Bethesda. The expansion permits PDA Education to increase its capacity for hands-on aseptic processing and lecture-based training at TRI.
The centerpiece of the buildout is a new 400 sq. ft. ISO Class 8 cleanroom that will house additional hands-on aseptic processing training courses. The cleanroom is enclosed by modular walls from Servicor and the air is processed with a HEPA air system.
"The hands-on aseptic processing instruction offered in an industrial setting at the Training and Research Institute is a critical component of PDA's educational program," said Craig Elliott, PDA Vice President of education. "PDA Education's Aseptic Processing Training Program provides an in-depth experience with the technologies associated with the manufacture of aseptically produced products, and now we have the capacity to train even more professionals each year."
PDA's aseptic processing program is highly valued and effective. "We've seen a dramatic increase in training demand recently, particularly from US regulators. Last year PDA trained over 300 US FDA personnel, but could not keep up with the increasing demand. This new capacity will allow us to meet the needs of the industry and the demand from regulators around the world," said Elliott.
PDA leads the pharmaceutical/biopharmaceutical industry in developing technical information and training in the areas of sterile drug manufacturing, aseptic processing, and other areas related to the manufacture and distribution of parenteral drug products.
"We offer a comprehensive and authoritative program in sterile manufacturing and aseptic processing that includes technical publications, articles, training and conferences," said Richard Johnson, PDA President.
Find out more about PDA Education's training courses in Aseptic Processing.